scholarly journals Management of Patients with Left Ventricular Assist Device during the COVID-19 Pandemic

Medicina ◽  
2022 ◽  
Vol 58 (1) ◽  
pp. 116
Author(s):  
Gassan Moady ◽  
Tuvia Ben Gal ◽  
Shaul Atar
Keyword(s):  
Left Ventricular Assist Device ◽  
Ventricular Assist Device ◽  
Cardiovascular Complications ◽  
Left Ventricular ◽  
The Novel ◽  
Assist Device ◽  
Ventricular Assist ◽  
Management Of Complications ◽  
Left Ventricular Assist ◽  
Novel Coronavirus

The novel coronavirus disease 2019 (COVID-19) is an infectious disease with multi-organ involvement, including the cardiovascular system. The disease may cause several cardiovascular complications, and may increase morbidity and mortality among patients with background cardiovascular disease. Patients with advanced heart failure are often treated with left ventricular assist device (LVAD), and represent a unique population mandating multi-disciplinary approach. Several aspects of COVID-19 should be taken into account in LVAD implants, including right ventricular involvement, hemodynamic alterations, thromboembolic and haemorrhagic complications, and the psychological effects of social isolation. Patients with VAD and suspected COVID-19 should be transferred to specialized centers for better management of complications. Here, we review the implications of COVID-19 pandemic on LVAD patients with our recommendations for appropriate management.

scholarly journals Novel Coronavirus Disease 2019 in a Patient on Durable Left Ventricular Assist Device Support

2020 ◽  
Vol 26 (5) ◽  
pp. 438-439 ◽  
Author(s):  
RAJAT SINGH ◽  
CHRISTOPHER DOMENICO ◽  
SRIRAM D. RAO ◽  
KIMBERLY URGO ◽  
STUART B. PRENNER ◽  
...  
Keyword(s):  
Left Ventricular Assist Device ◽  
Ventricular Assist Device ◽  
Left Ventricular ◽  
Assist Device ◽  
Ventricular Assist ◽  
Left Ventricular Assist ◽  
Novel Coronavirus

scholarly journals Left Ventricular Assist Device Implantation to a Child with End Stage Heart Failure In The Novel Coronavirus Pandemic Period

2020 ◽  
Author(s):  
Tanıl Özer ◽  
Deniz Günay ◽  
Mehmet Aksüt ◽  
Özge Altaş ◽  
Emre Gürcü ◽  
...  
Keyword(s):  
Heart Failure ◽  
Left Ventricular Assist Device ◽  
Left Ventricular ◽  
The Novel ◽  
Assist Device ◽  
Ventricular Assist ◽  
Left Ventricular Assist ◽  
End Stage Heart Failure ◽  
Novel Coronavirus ◽  
End Stage

Abstract At the end of the 2019, a novel coronavirus disease (COVID-19) appeared in Wuhan, China and spread rapidly to all over the world. Then, the attentions of almost all health care providers have shifted to this health emergency situation which is identified as pandemic. The novel coronavirus pandemic has impacted the physicians at the all field of medicine not to perform their routine treatment practice. Since it is not clear when this situation will end, there is still debate about how to manage the treatment strategies for the patients who have end stage heart failure such another life threatening illness. The aim of this case presentation is to create a consideration about timing of left ventricular assist device implantations during novel coronavirus pandemic period.

Ultrastructural observations of the aorta of calves implanted with a mechanical left ventricular assist device

1990 ◽  
Vol 48 (3) ◽  
pp. 834-835
Author(s):  
J P Cassella ◽  
V Salih ◽  
T R Graham
Keyword(s):  
Left Ventricular Assist Device ◽  
Ventricular Assist Device ◽  
Left Ventricular ◽  
Aortic Tissue ◽  
Assist Device ◽  
Ventricular Assist ◽  
Transmission Electron ◽  
Left Ventricular Assist ◽  
Preliminary Study

Left ventricular assist systems are being developed for eventual long term or permanent implantation as an alternative to heart transplantation in patients unsuitable for or denied the transplant option. Evaluation of the effects of these devices upon normal physiology is required. A preliminary study was conducted to evaluate the morphology of aortic tissue from calves implanted with a pneumatic Left Ventricular Assist device-LVAD. Two 3 month old heifer calves (calf 1 and calf 2) were electively explanted after 128 days and 47 days respectively. Descending thoracic aortic tissue from both animals was removed immediately post mortem and placed into karnovsky’s fixative. The tissue was subsequently processed for transmission electron microscopy (TEM). Some aortic tissue was fixed in neutral buffered formalin and processed for routine light microscopy.

Sign in / Sign up

Export Citation Format

Share Document